Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission.
暂无分享,去创建一个
A. Alberti | G. Masera | A. Tagger | H. Shulman | A. Locasciulli | L. Cavalletto | D. Cavalletto | M. Ribero | B. Portmann | G. Gornati | M. L. Ribero
[1] A. Alberti,et al. Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis. , 1991, Journal of hepatology.
[2] P. Pontisso,et al. Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases. , 1990, Bone marrow transplantation.
[3] H. Reesink,et al. Infectivity of blood seropositive for hepatitis C virus antibodies , 1990, The Lancet.
[4] M. Lenzi,et al. Type 2 autoimmune hepatitis and hepatitis C virus infection , 1990, The Lancet.
[5] J. Rosenblatt,et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis , 1990, The Lancet.
[6] H J Alter,et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. , 1990, Science.
[7] R. Purcell,et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.
[8] A. Alberti,et al. ANTIBODIES TO HEPATITIS C VIRUS IN CHILDREN WITH ACUTE OR CHRONIC VIRAL HEPATITIS , 1989, The Lancet.
[9] Jules L. Dienstag,et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .
[10] M. Houghton,et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.
[11] E. Schiff,et al. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. , 1989, The New England journal of medicine.
[12] A. Alberti,et al. Hepatitis B virus markers in children with acute leukemia: The effect of chemotherapy , 1985, Journal of medical virology.
[13] A. Alberti,et al. Acute and chronic hepatitis in childhood leukemia: a multicentric study from the Italian Pediatric Cooperative Group for Therapy of Acute Leukemia (AIL-AIEOP). , 1985, Medical and pediatric oncology.
[14] G. McDonald,et al. Intestinal and liver toxicity of antineoplastic drugs. , 1984, The Western journal of medicine.
[15] D. Vergani,et al. Chronic liver disease in children with leukemia in long‐term remission , 1983, Cancer.
[16] A. Alberti,et al. Evidence of non-A, non-B hepatitis in children with acute leukemia and chronic liver disease. , 1983, American journal of diseases of children.
[17] D. Vergani,et al. HISTOLOGICAL EVIDENCE OF HEPATITIS-B-VIRUS INFECTION WITH NEGATIVE SEROLOGY IN CHILDREN WITH ACUTE LEUKAEMIA WHO DEVELOP CHRONIC LIVER DISEASE , 1982, The Lancet.
[18] R. Novak,et al. Outcome of hepatitis in children with acute leukemia. , 1980, American journal of diseases of children.
[19] D. Dhumeaux,et al. Antineoplastic agents and the liver. , 1980, Gastroenterology.
[20] J. Barton,et al. Beneficial effects of hepatitis in patients with acute myelogenous leukemia. , 1979, Annals of internal medicine.
[21] E. Tabor,et al. Prevalence of hepatitis B in a high-risk setting: a serologic study of patients and staff in a pediatric oncology unit. , 1978, Pediatrics.
[22] J. Armitage,et al. Liver disease complicating the management of acute leukemia during remission , 1978, Cancer.
[23] J. Wands,et al. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. , 1975, Gastroenterology.